• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠肺炎患者出院后新冠病毒再次阳性的风险因素。

Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.

机构信息

Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Luqiao, Zhejiang 318050, China.

Department of Pediatrics, Taizhou Hospital of Zhejiang Province, Luqiao, Zhejiang 318050, China.

出版信息

Int Immunopharmacol. 2021 Jun;95:107579. doi: 10.1016/j.intimp.2021.107579. Epub 2021 Mar 12.

DOI:10.1016/j.intimp.2021.107579
PMID:33756229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953440/
Abstract

OBJECTIVE

Re-positivity of SARS-CoV-2 in discharged COVID-19 patients have been reported; however, early risk factors for SARS-CoV-2 re-positivity evaluation are limited.

METHODS

This is a prospective study, a total of 145 COVID-19 patients were treated and all discharged according to the guideline criteria by Mar 11th 2020. After discharge, clinical visits and viral RT-PCR tests by the second and fourth week follow-up were carried-out. Patient demographic and clinical characteristics and laboratory data on admission and discharge were retrieved, and predictive factors for SARS-CoV-2 re-positivity were analyzed.

RESULTS

13 out of 145 (9.0%) COVID-19 patients were confirmed re-positivity of SARS-CoV-2 by RT-PCR test. The median interval between disease onset to recurrence was 38 days. SARS-CoV-2 re-positive cases were of significantly longer virus shedding duration, notably higher body temperature, heart rate and lower TNF-α and IgG levels on admission. Covariate logistic regression analysis revealed virus shedding duration and IgG levels are independent risk factors for SARS-CoV-2 return positive after discharge.

CONCLUSION

Longer viral shedding duration and lower IgG levels are risk factors for re-positivity of SARS-CoV-2 for discharged COVID-19 patients.

摘要

目的

已报道出院的 COVID-19 患者中 SARS-CoV-2 的再阳性;然而,SARS-CoV-2 再阳性评估的早期危险因素有限。

方法

这是一项前瞻性研究,共有 145 例 COVID-19 患者于 2020 年 3 月 11 日按照指南标准进行治疗和出院。出院后,进行第二次和第四次随访的临床就诊和病毒 RT-PCR 检测。检索患者的人口统计学和临床特征以及入院和出院时的实验室数据,并分析 SARS-CoV-2 再阳性的预测因素。

结果

145 例 COVID-19 患者中,有 13 例(9.0%)通过 RT-PCR 检测证实 SARS-CoV-2 再阳性。从发病到复发的中位间隔时间为 38 天。SARS-CoV-2 再阳性病例的病毒脱落持续时间明显更长,入院时体温、心率显著更高,TNF-α和 IgG 水平显著更低。协变量逻辑回归分析显示,病毒脱落持续时间和 IgG 水平是出院后 SARS-CoV-2 再次阳性的独立危险因素。

结论

较长的病毒脱落持续时间和较低的 IgG 水平是出院 COVID-19 患者 SARS-CoV-2 再阳性的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/7953440/3e32fd6d5a57/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/7953440/3e32fd6d5a57/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa2/7953440/3e32fd6d5a57/gr1_lrg.jpg

相似文献

1
Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.新冠肺炎患者出院后新冠病毒再次阳性的风险因素。
Int Immunopharmacol. 2021 Jun;95:107579. doi: 10.1016/j.intimp.2021.107579. Epub 2021 Mar 12.
2
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.恢复期患者 SARS-CoV-2 RNA 复阳的临床特征及潜在影响因素:一项回顾性队列研究。
Clin Exp Med. 2021 Aug;21(3):361-367. doi: 10.1007/s10238-021-00687-y. Epub 2021 Feb 4.
3
A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region.宁夏回族自治区感染 SARS-CoV-2 Delta 变异株病毒核酸复阳与非复阳患者的对比研究。
Front Public Health. 2022 Dec 13;10:1023797. doi: 10.3389/fpubh.2022.1023797. eCollection 2022.
4
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
5
Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation.出院后 COVID-19 患者在医学隔离观察期间的重复实时 RT-PCR 检测。
Int J Med Sci. 2021 Apr 26;18(12):2545-2550. doi: 10.7150/ijms.58766. eCollection 2021.
6
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.出院新冠患者中 SARS-CoV-2 病毒 RNA 再阳性的差异。
AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023.
7
Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病患者的血清学评估。
PLoS One. 2022 Jan 20;17(1):e0262820. doi: 10.1371/journal.pone.0262820. eCollection 2022.
8
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.新冠病毒感染治愈患者中 SARS-CoV-2 病毒 RNA 复阳:一项叙述性综述。
Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):13-25. doi: 10.1007/s10096-020-04088-z. Epub 2020 Oct 28.
9
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
10
Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.儿童严重急性呼吸综合征冠状病毒 2 感染患者各年龄段病毒清除和抗体产生动力学。
J Pediatr. 2020 Dec;227:31-37.e1. doi: 10.1016/j.jpeds.2020.08.078. Epub 2020 Sep 3.

引用本文的文献

1
Clinical characteristics and prediction model of re-positive nucleic acid tests among Omicron infections by machine learning: a real-world study of 35,488 cases.机器学习分析奥密克戎感染后核酸复阳的临床特征及预测模型:一项对35488例病例的真实世界研究
BMC Infect Dis. 2024 Dec 18;24(1):1406. doi: 10.1186/s12879-024-10297-0.
2
Metabolic Syndrome Is Associated with Poor Omicron Infection Prognosis While Inactivated Vaccine Improves the Outcome of Coronavirus Disease 2019 among Chinese Inhabitants: A Retrospective Observational Study from a Chinese Municipality.代谢综合征与奥密克戎感染预后不良相关,而灭活疫苗可改善中国居民2019冠状病毒病的预后:一项来自中国某直辖市的回顾性观察研究。
Vaccines (Basel). 2023 Sep 30;11(10):1554. doi: 10.3390/vaccines11101554.
3

本文引用的文献

1
Factors associated with delayed viral shedding in COVID-19 infected patients: A retrospective small-scale study.与 COVID-19 感染患者病毒延迟脱落相关的因素:一项回顾性小规模研究。
Respir Med. 2021 Mar;178:106328. doi: 10.1016/j.rmed.2021.106328. Epub 2021 Feb 6.
2
Prevalence and impact factors of recurrent positive SARS-CoV-2 detection in 599 hospitalized COVID-19 patients.599例住院COVID-19患者中SARS-CoV-2检测反复呈阳性的患病率及影响因素
Clin Microbiol Infect. 2021 Feb 9;27(5):785.e1-7. doi: 10.1016/j.cmi.2021.01.028.
3
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region.宁夏回族自治区感染 SARS-CoV-2 Delta 变异株病毒核酸复阳与非复阳患者的对比研究。
Front Public Health. 2022 Dec 13;10:1023797. doi: 10.3389/fpubh.2022.1023797. eCollection 2022.
4
Clinical Characteristics in Patients with Redetected Positive RNA Test After Recovery from Foreign-Imported COVID-19 Cases in Xi'an, China.中国西安境外输入型新冠肺炎病例康复后核酸检测再次阳性患者的临床特征
Infect Drug Resist. 2022 Jun 24;15:3295-3307. doi: 10.2147/IDR.S371088. eCollection 2022.
5
Clinical and Gene Features of SARS-CoV-2-Positive Recurrence in Patients Recovered From COVID-19.新型冠状病毒肺炎康复患者中新冠病毒阳性复发的临床和基因特征
Front Mol Biosci. 2022 Jun 8;9:875418. doi: 10.3389/fmolb.2022.875418. eCollection 2022.
6
Systematic Review on COVID-19 Readmission and Risk Factors: Future of Machine Learning in COVID-19 Readmission Studies.对 COVID-19 再入院和危险因素的系统评价:机器学习在 COVID-19 再入院研究中的未来。
Front Public Health. 2022 May 23;10:898254. doi: 10.3389/fpubh.2022.898254. eCollection 2022.
7
Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.HLA-G 在 SARS-CoV-2 感染中诱导免疫抑制的观点。
Front Immunol. 2021 Dec 6;12:788769. doi: 10.3389/fimmu.2021.788769. eCollection 2021.
8
Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis.临床特征和 SARS-CoV-2 RNA 复阳的独立预测因素:倾向评分匹配分析。
J Med Virol. 2022 Apr;94(4):1402-1411. doi: 10.1002/jmv.27450. Epub 2021 Nov 18.
9
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.反复 SARS-CoV-2 阳性患者的免疫球蛋白反应和预后因素:系统评价和荟萃分析。
Viruses. 2021 Apr 30;13(5):809. doi: 10.3390/v13050809.
长期严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)在 3 名免疫功能低下患者中的传染性:从延长的病毒脱落到 SARS-CoV-2 再感染。
J Infect Dis. 2021 May 20;223(9):1522-1527. doi: 10.1093/infdis/jiab075.
4
Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study.慢性鼻-鼻窦炎与上呼吸道样本中 SARS-CoV-2 RNA 持续脱落相关:一项病例对照研究。
J Intern Med. 2021 Jun;289(6):921-925. doi: 10.1111/joim.13237. Epub 2021 Feb 9.
5
Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis.新冠病毒(SARS-CoV-2)感染后持续阳性:系统评价和荟萃分析。
Sci Rep. 2020 Nov 26;10(1):20692. doi: 10.1038/s41598-020-77739-y.
6
Decoding Asymptomatic COVID-19 Infection and Transmission.解读无症状新冠病毒感染与传播
J Phys Chem Lett. 2020 Dec 3;11(23):10007-10015. doi: 10.1021/acs.jpclett.0c02765. Epub 2020 Nov 12.
7
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.新冠病毒核酸检测复阳康复患者的临床特征
Ann Transl Med. 2020 Sep;8(17):1084. doi: 10.21037/atm-20-5602.
8
Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.来自单一中心的感染和康复患者的 SARS-CoV-2 阳性动力学。
Sci Rep. 2020 Oct 29;10(1):18629. doi: 10.1038/s41598-020-75629-x.
9
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.新冠病毒感染治愈患者中 SARS-CoV-2 病毒 RNA 复阳:一项叙述性综述。
Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):13-25. doi: 10.1007/s10096-020-04088-z. Epub 2020 Oct 28.
10
Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China.新型冠状病毒2019(SARS-CoV-2)RNA阳性患者的临床病程及复发危险因素:一项来自中国武汉的回顾性队列研究
Aging (Albany NY). 2020 Sep 10;12(17):16675-16689. doi: 10.18632/aging.103795.